GB0425064D0 - Compounds useful for the treatment of diseases - Google Patents

Compounds useful for the treatment of diseases

Info

Publication number
GB0425064D0
GB0425064D0 GB0425064A GB0425064A GB0425064D0 GB 0425064 D0 GB0425064 D0 GB 0425064D0 GB 0425064 A GB0425064 A GB 0425064A GB 0425064 A GB0425064 A GB 0425064A GB 0425064 D0 GB0425064 D0 GB 0425064D0
Authority
GB
United Kingdom
Prior art keywords
diseases
treatment
compounds useful
compounds
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0425064A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0425064A priority Critical patent/GB0425064D0/en
Publication of GB0425064D0 publication Critical patent/GB0425064D0/en
Priority to PCT/IB2005/000640 priority patent/WO2005090287A2/en
Priority to EA200601510A priority patent/EA200601510A1/en
Priority to EP05708731A priority patent/EP1727789A2/en
Priority to KR1020067019104A priority patent/KR20070026420A/en
Priority to AU2005223488A priority patent/AU2005223488A1/en
Priority to JP2007503437A priority patent/JP4054366B2/en
Priority to AP2006003743A priority patent/AP2006003743A0/en
Priority to BRPI0508927-1A priority patent/BRPI0508927A/en
Priority to CA002559203A priority patent/CA2559203A1/en
Priority to UY28810A priority patent/UY28810A1/en
Priority to ARP050101000A priority patent/AR048267A1/en
Priority to PE2005000297A priority patent/PE20060123A1/en
Priority to TW094107960A priority patent/TWI281396B/en
Priority to US11/083,265 priority patent/US7629358B2/en
Priority to SV2005002052A priority patent/SV2005002052A/en
Priority to NL1028559A priority patent/NL1028559C2/en
Priority to PA20058626401A priority patent/PA8626401A1/en
Priority to IL177754A priority patent/IL177754A0/en
Priority to NO20063875A priority patent/NO20063875L/en
Priority to TNP2006000286A priority patent/TNSN06286A1/en
Priority to EC2006006854A priority patent/ECSP066854A/en
Priority to MA29328A priority patent/MA28475B1/en
Priority to IS8549A priority patent/IS8549A/en
Ceased legal-status Critical Current

Links

GB0425064A 2004-03-17 2004-11-12 Compounds useful for the treatment of diseases Ceased GB0425064D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases
PCT/IB2005/000640 WO2005090287A2 (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as beta-2 agonists
EA200601510A EA200601510A1 (en) 2004-03-17 2005-03-10 DERIVATIVES OF PHENYLETHANOLAMINE AS BETA-2-AGONISTS
EP05708731A EP1727789A2 (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as beta-2 agonists
KR1020067019104A KR20070026420A (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as beta-2 agonists
AU2005223488A AU2005223488A1 (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as Beta-2 agonists
JP2007503437A JP4054366B2 (en) 2004-03-17 2005-03-10 Compounds useful for the treatment of diseases
AP2006003743A AP2006003743A0 (en) 2004-03-17 2005-03-10 Compounds useful for the treatment of diseases
BRPI0508927-1A BRPI0508927A (en) 2004-03-17 2005-03-10 compounds useful for treating diseases
CA002559203A CA2559203A1 (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as beta-2 agonists
ARP050101000A AR048267A1 (en) 2004-03-17 2005-03-15 USEFUL COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY, ALLERGIC AND RESPIRATORY AFFECTIONS
UY28810A UY28810A1 (en) 2004-03-17 2005-03-15 USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
PE2005000297A PE20060123A1 (en) 2004-03-17 2005-03-15 DERIVATIVES OF PHENYLETHANOLAMINE AS ß-2 AGONISTS
TW094107960A TWI281396B (en) 2004-03-17 2005-03-16 Compounds useful for the treatment of diseases
US11/083,265 US7629358B2 (en) 2004-03-17 2005-03-16 Compounds useful for the treatment of diseases
SV2005002052A SV2005002052A (en) 2004-03-17 2005-03-16 USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES REF. PC32198A
NL1028559A NL1028559C2 (en) 2004-03-17 2005-03-16 Compounds useful for the treatment of diseases
PA20058626401A PA8626401A1 (en) 2004-03-17 2005-03-17 USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
IL177754A IL177754A0 (en) 2004-03-17 2006-08-29 Phenylethanolamine derivatives as beta-2 agonists
NO20063875A NO20063875L (en) 2004-03-17 2006-08-30 Compounds used for the treatment of diseases
TNP2006000286A TNSN06286A1 (en) 2004-11-12 2006-09-15 COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
EC2006006854A ECSP066854A (en) 2004-03-17 2006-09-15 USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
MA29328A MA28475B1 (en) 2004-03-17 2006-09-15 Compounds useful for the treatment of diseases
IS8549A IS8549A (en) 2004-11-12 2006-10-06 Phenylthanolamine derivatives acting as beta-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases

Publications (1)

Publication Number Publication Date
GB0425064D0 true GB0425064D0 (en) 2004-12-15

Family

ID=33523663

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0425064A Ceased GB0425064D0 (en) 2004-03-17 2004-11-12 Compounds useful for the treatment of diseases

Country Status (3)

Country Link
GB (1) GB0425064D0 (en)
IS (1) IS8549A (en)
TN (1) TNSN06286A1 (en)

Also Published As

Publication number Publication date
TNSN06286A1 (en) 2007-12-03
IS8549A (en) 2006-10-06

Similar Documents

Publication Publication Date Title
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
EP1804794A4 (en) Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer s disease
HK1096083A1 (en) Sulfonamide derivatives for the treatment of diseases
IL194076A0 (en) Imidazolothiazole compounds for the treatment of disease
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
IL195571A0 (en) Compounds for the treatment of periodontal disease
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
EP1789034A4 (en) Compounds with diphenoyl -structure for the treatment of immune diseases
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
GB0329874D0 (en) Compounds useful for the treatment of diseases
PL1801108T3 (en) Morpholine compounds for the treatment of inflammations
EP1750698A4 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
HK1097831A1 (en) Benzopyran compounds useful for the treatment of arrhytmia
HU0500145D0 (en) Composition for the treatment of oral diseases
GB0400802D0 (en) Compounds for the treatment of disease
ZA200606780B (en) Compounds for the treatment of diseases
GB0425064D0 (en) Compounds useful for the treatment of diseases
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
IL175611A0 (en) Combinations for the treatment of proliferative diseases
GB0415352D0 (en) Compounds for the treatment of disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)